Work

A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML

Year: 2025

Type: preprint

Source: Research Square

DOI: 10.21203/rs.3.rs-7763372/v1

Institutions: Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Heart, Lung, and Blood Institute, National Cancer Institute

Awards: T32: Predoctoral and Postdoctoral Training Program in Nanotechnology for Cancer Research, TCR Targeting Antibodies for the Treatment of T cell Cancers, CCRL2 as a Regulator of Growth and Novel Target in Myelodysplastic Syndrome

OpenAlex ID: W4415649240

Cites: 31

Cited by:

Related to: 10